City
Epaper

WHO has lifted barriers for Sputnik V approval: Russian Health Minister

By ANI | Updated: October 2, 2021 18:30 IST

All obstacles preventing the certification of the Russian Sputnik V vaccine against coronavirus by the World Health Organization (WHO) have been removed, Russian Health Minister Mikhail Murashko said at a briefing in Geneva.

Open in App

All obstacles preventing the certification of the Russian Sputnik V vaccine against coronavirus by the World Health Organization (WHO) have been removed, Russian Health Minister Mikhail Murashko said at a briefing in Geneva.

"All barriers have been lifted as of today. We do not see any obstacles for continuing our work. This was confirmed by the WHO director general," Murashko said at a briefing in Geneva in response to a question by Russian News Agency TASS.

Russia first applied for approval from the WHO for their vaccine in February but has not yet received an Emergency Use Listing (EUL).

The Russian COVID-19 vaccine Sputnik V is an adenoviral-based, two-part vaccine against the SARS-CoV-2 coronavirus. Produced in Russia, Sputnik V uses a weakened virus to deliver small parts of a pathogen and stimulate an immune response.

Murashko met WHO Director-General Tedros Adhanom Ghebreyesus here during which the procedure of including Sputnik V in the list of vaccines recommended by the organization for the emergency use listing for fighting the coronavirus infection was discussed.

Following the meeting, the Russian health minister said: "The position of the Russian Federation on promoting and registering the Russian Sputnik V vaccine was heard. We have completely resolved all issues to date."

The efficacy of the Sputnik V vaccine is confirmed at 91.6 per cent, the results of a Phase III clinical trial of the vaccine are published in the Lancet, one of the world's oldest and most respected medical journals, as per the Russian Direct Investment Fund.

According to the analysis of data from 3.8 million vaccinated persons in Russia Sputnik V demonstrates 97.6 per cent efficacy.

The vaccine provides 100 per cent protection against severe COVID-19.

Sputnik V vaccine is approved by 70 countries with a total population of 4 billion people - over 50 per cent of the world population. The vaccine supplies for the global market will be produced by RDIF's international partners in India, Brazil, China, South Korea and other countries.

Last month, the World Health Organization had suspended the approval process for Russia's Sputnik V COVID vaccine.

A regional WHO official said the manufacturing process of the jab had not met the necessary standards.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: TASSRussiaGenevaWorld Health OrganizationWhoWorld healthMikhail murashkoU of u healthFinance and healthNational public health organizationKati assembly
Open in App

Related Stories

InternationalPoland Shuts Airports After Russian Drones Sighted in Airspace; Polish Armed Forces Neutralising Flying Objects

EntertainmentBhumi Satish Pednekar Becomes the First Indian Actress to Attend the Young Global Leaders Summit 2025 in Geneva

InternationalPM Narendra Modi, Chinese President Xi Jinping and Russian President Vladimir Putin Seen Interacting at SCO Summit 2025 in China

NationalDonald Trump Imposes Additional 25% Tariff on India, Total Tariff Now 50%

InternationalEarthquake of Magnitude 8.8 Is Equal to Explosion of 15,900 Atomic Bombs Like Hiroshima, Claims Grok

International Realted Stories

International"We feel a sense of belonging coming to India, especially to Varanasi": Mauritius delegate Kevin C Lukeeram

InternationalBaloch activists write to 9/11 victims, expose link between Pakistani agencies and terror groups

InternationalUkrainian President thanks Japan, UK for renewed sanctions against Russia

InternationalUAE summons Israeli envoy, condemns strike on Hamas leaders in Qatar

InternationalOutgoing Japanese PM Ishiba considering visiting South Korea later this month